Jenburkt Pharmaceuticals share news and announcements
NSE: JENBURPHBSE: 524731Pharmaceuticals & BiotechnologySmall Cap
Last close ₹870.95down ₹0.45 (0.05%)BSE ₹860.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹871.40.
52-week range of BSE trades to 23 Oct 2026
₹852.00Low, 23 Oct 2026₹1,321.00High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹384 Cr1,871st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 11.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.38%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 17.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.95 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 19.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,34093.5% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Jenburkt Pharmaceuticals quarterly results
Aug6Thu
The board met on 6 Aug 2026 to consider quarterly results
Notice filed 29 Jul 2026
Jenburkt Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Jenburkt Pharmaceuticals financials, year by year
Annual reports30
- Annual report, year to Mar 2026 (opens in a new tab)3 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)20 Jun 2025
- Annual report, year to Mar 2024 (opens in a new tab)2 Jul 2024
- Annual report, year to Mar 2023 (opens in a new tab)30 Jun 2023
- Annual report, year to Mar 2022 (opens in a new tab)1 Jul 2022
25 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)2 Aug 2021
- Annual report, year to Mar 2020 (opens in a new tab)4 Aug 2020
- Annual report, year to Mar 2019 (opens in a new tab)25 Jun 2019
- Annual report, year to Mar 2018 (opens in a new tab)1 Aug 2018
- Annual report, year to Mar 2017 (opens in a new tab)2 Aug 2017
- Annual report, year to Mar 2016 (opens in a new tab)29 Jul 2016
- Annual report, year to Mar 2015 (opens in a new tab)13 Aug 2015
- Annual report, year to Mar 2014 (opens in a new tab)12 Aug 2014
- Annual report, year to Mar 2013 (opens in a new tab)30 Aug 2013
- Annual report, year to Mar 2012 (opens in a new tab)3 Jul 2012
- Annual report, year to Mar 2011 (opens in a new tab)6 Jul 2011
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2001 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1998 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1997 (opens in a new tab)Filing day not known
Jenburkt Pharmaceuticals share news and announcements
651 announcements, routine notices left out, newest first. Page 1 of 14.
Oct 2026
Sep 2026
22 Sep · Intimation Regarding Admission Of Equity Shares Of The Company Under 'Permitted To Trade' Category On National Stock Exchange Of India Limited.
Aug 2026
Jul 2026
29 Jul · Board meeting
Meeting on 6 Aug 2026: quarterly results13 Jul · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
May 2026
Apr 2026
28 Apr · Board meeting
Meeting on 5 May 2026: annual general meeting, audited results, final dividend and quarterly results
Feb 2026
Jan 2026
28 Jan · Board meeting
Meeting on 3 Feb 2026: quarterly results
Oct 2025
3 Oct · Board meeting
Meeting on 28 Oct 2025: quarterly results
Aug 2025
1 Aug · Board meeting
Meeting on 12 Aug 2025: quarterly results
Jul 2025
18 Jul · Management
Jun 2025
May 2025
20 May · Board meeting
12 May · Board meeting
Meeting on 20 May 2025: audited results and final dividend
Mar 2025
Feb 2025
Jan 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 6 May 2026 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 21 Sep 2026Board or managers changeddown 0.03%−0.1 pts vs Nifty 500market median 0.0% · five sessions −3.3% (−2.2 pts vs Nifty 500) · volume 0.9× usual · delivery −10.6 pts against usual · The announcement (opens in a new tab)
- 4 Sep 2026Board or managers changedup 0.71%+0.7 pts vs Nifty 500market median 0.0% · five sessions −0.5% (+0.8 pts vs Nifty 500) · delivery +4.1 pts against usual · The announcement (opens in a new tab)
- 6 May 2026Board or managers changedup 7.11%+5.7 pts vs Nifty 500market median 0.0% · five sessions +8.5% (+10.7 pts vs Nifty 500) · volume 12.5× usual · The announcement (opens in a new tab)
- 6 May 2026Dividendup 7.11%+5.7 pts vs Nifty 500market median 0.0% · five sessions +8.5% (+10.7 pts vs Nifty 500) · volume 12.5× usual · The announcement (opens in a new tab)
- 29 Apr 2026Dividendup 0.47%0.0 pts vs Nifty 500market median 0.0% · five sessions +10.4% (+8.8 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 21 Jul 2025Board or managers changedup 1.68%+1.2 pts vs Nifty 500market median 0.0% · five sessions +1.8% (+2.9 pts vs Nifty 500) · volume 1.6× usual · The announcement (opens in a new tab)
- 21 May 2025Board or managers changedup 1.75%+1.1 pts vs Nifty 500market median 0.0% · five sessions +3.0% (+2.0 pts vs Nifty 500) · volume 5.4× usual · The announcement (opens in a new tab)
- 21 May 2025Dividendup 1.75%+1.1 pts vs Nifty 500market median 0.0% · five sessions +3.0% (+2.0 pts vs Nifty 500) · volume 5.4× usual · The announcement (opens in a new tab)
- 13 May 2025Board or managers changedup 0.57%+1.3 pts vs Nifty 500market median 0.0% · five sessions +7.1% (+5.6 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 12 May 2025Dividendup 2.39%−1.5 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+2.7 pts vs Nifty 500) · volume 1.1× usual · The announcement (opens in a new tab)
20 earlier announcements
- 27 Feb 2025Board or managers changeddown 2.56%−2.1 pts vs Nifty 500market median 0.0% · five sessions +0.1% (+0.9 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 21 May 2024Dividendup 0.38%+0.2 pts vs Nifty 500market median 0.0% · five sessions +2.3% (+0.7 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 15 Apr 2024Board or managers changeddown 1.47%−0.2 pts vs Nifty 500market median 0.0% · five sessions −1.6% (−0.7 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 24 May 2023Dividendup 4.08%+4.3 pts vs Nifty 500market median 0.0% · five sessions +3.9% (+2.3 pts vs Nifty 500) · volume 9.6× usual · The announcement (opens in a new tab)
- 27 Mar 2023Buybackup 0.80%+0.9 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−4.2 pts vs Nifty 500) · volume 0.0× usual · The announcement (opens in a new tab)
- 24 Mar 2023Buybackup 1.80%+2.7 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−1.8 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 23 Mar 2023Buybackdown 3.49%−3.1 pts vs Nifty 500market median 0.0% · five sessions −5.1% (−4.3 pts vs Nifty 500) · volume 2.0× usual · The announcement (opens in a new tab)
- 22 Mar 2023Buybackdown 1.31%−1.7 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−0.4 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 21 Mar 2023Buybackup 2.06%+1.4 pts vs Nifty 500market median 0.0% · five sessions −0.3% (+0.1 pts vs Nifty 500) · volume 2.1× usual · The announcement (opens in a new tab)
- 20 Mar 2023Buybackup 0.62%+1.3 pts vs Nifty 500market median 0.0% · five sessions −0.4% (+0.5 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 17 Mar 2023Buybackup 3.96%+3.3 pts vs Nifty 500market median 0.0% · five sessions +1.7% (+1.2 pts vs Nifty 500) · volume 1.9× usual · The announcement (opens in a new tab)
- 16 Mar 2023Buybackup 0.16%+0.1 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+4.6 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 15 Mar 2023Buybackdown 0.22%0.0 pts vs Nifty 500market median 0.0% · five sessions +6.7% (+6.3 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 14 Mar 2023Buybackup 0.42%+1.1 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+5.9 pts vs Nifty 500) · volume 6.9× usual · The announcement (opens in a new tab)
- 13 Mar 2023Buybackup 0.94%+2.5 pts vs Nifty 500market median 0.0% · five sessions +5.3% (+7.1 pts vs Nifty 500) · volume 1.5× usual · The announcement (opens in a new tab)
- 10 Mar 2023Buybackdown 0.97%−0.1 pts vs Nifty 500market median 0.0% · five sessions +0.3% (+3.5 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 9 Mar 2023Buybackup 1.32%+2.1 pts vs Nifty 500market median 0.0% · five sessions +1.5% (+5.5 pts vs Nifty 500) · volume 1.3× usual · The announcement (opens in a new tab)
- 8 Mar 2023Buybackup 1.30%+1.0 pts vs Nifty 500market median 0.0% · five sessions +3.0% (+6.5 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 6 Mar 2023Buybackdown 0.16%−0.9 pts vs Nifty 500market median 0.0% · five sessions +2.4% (+4.6 pts vs Nifty 500) · volume 2.3× usual · The announcement (opens in a new tab)
- 3 Mar 2023Buybackup 1.25%0.0 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+2.1 pts vs Nifty 500) · volume 2.1× usual · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash at the end of the period | At Sep 2025 | Standalone | −1.93 | 5.44 | +381.6% | 28 Oct 2025 (opens in a new tab) | 30 Dec 2025 (opens in a new tab) |